Press Releases

Sign up for Email Alerts Press Release RSS

09/20/2019
Bristol-Myers Squibb to Hold Investor Webcast to Discuss ESMO Highlights
Term:Bristol-Myers
Language:English
09/19/2019
Bristol-Myers Squibb Research at ESMO Demonstrates Breadth of Oncology Development Program and Focus on Improving Overall Survival Across Multiple Cancers
Term:Corporate/Financial News
Language:English
09/12/2019
Bristol-Myers Squibb to Announce Results for Third Quarter 2019 on October 31, 2019
Term:Corporate/Financial News
Language:English
09/11/2019
Bristol-Myers Squibb Board Announces Election of Three New Directors
Term:Corporate/Financial News
Language:English
09/11/2019
Bristol‑Myers Squibb Announces Dividend
Term:Corporate/Financial News
Language:English
09/10/2019
Bristol-Myers Squibb Announces Pooled Five-Year Survival Results for Opdivo (nivolumab) in Previously-Treated Advanced Non-Small Cell Lung Cancer Patients
Term:Corporate/Financial News
Language:English
09/05/2019
Bristol-Myers Squibb Provides Update on Phase 3 Opdivo (nivolumab) CheckMate -548 Trial in Patients with Newly Diagnosed MGMT-Methylated Glioblastoma Multiforme
Term:Corporate/Financial News
Language:English
09/04/2019
More Than 100 Bristol-Myers Squibb Employees Embark on Coast 2 Coast 4 Cancer Ride to Help Advance Groundbreaking Cancer Research
Term:Corporate/Financial News
Language:English
09/03/2019
Bristol-Myers Squibb to Take Part at the Morgan Stanley Conference
Term:Corporate/Financial News
Language:English
09/01/2019
Findings Released from NAXOS, a French Real-World Data Analysis and the Largest Real-World Data Analysis on Oral Anticoagulant Effectiveness and Safety in Europe Among Patients with Non-Valvular Atrial Fibrillation
Term:R&D News
Language:English

Business Wire NewsHQ^sm